$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

$rmti Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000162828020016121 Filed on November 09, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$15.16M	$15.28M	$15.41M
YoY Change	-2.13%	-0.82%	-7.58%
Cost Of Revenue	$14.78M	$14.93M	$15.42M
YoY Change	2.78%	-3.18%	4.93%
Gross Profit	$390.0K	$346.0K	-$17.00K
YoY Change	-64.86%	-2135.29%	-100.86%
Gross Profit Margin	2.57%	2.26%	-0.11%
Selling, General & Admin	$6.550M	$5.291M	$6.450M
YoY Change	-0.15%	-17.97%	4.71%
% of Gross Profit	1679.49%	1529.19%
Research & Development	$1.910M	$1.745M	$1.475M
YoY Change	-2.55%	18.31%	82.1%
% of Gross Profit	489.74%	504.34%
Depreciation & Amortization	$220.0K	$200.0K	$200.0K
YoY Change	4.76%	0.0%	5.26%
% of Gross Profit	56.41%	57.8%
Operating Expenses	$8.460M	$7.036M	$7.925M
YoY Change	-0.59%	-11.22%	13.7%
Operating Profit	-$8.070M	-$6.690M	-$7.942M
YoY Change	9.05%	-15.76%	58.84%
Interest Expense	-$590.0K	$666.0K	$16.00K
YoY Change	-690.0%	4062.5%	-46.67%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$660.0K	$87.00K
YoY Change		-858.62%
Pretax Income	-$8.660M	-$7.350M	-$7.860M
YoY Change	18.63%	-6.49%	58.15%
Income Tax
% Of Pretax Income
Net Earnings	-$8.660M	-$7.350M	-$7.855M
YoY Change	18.63%	-6.43%	58.05%
Net Earnings / Revenue	-57.12%	-48.1%	-50.98%
Basic Earnings Per Share		-$0.10
Diluted Earnings Per Share	-$92.42K	-$0.10	-$123.2K
COMMON SHARES
Basic Shares Outstanding	93.57M shares	71.81M shares
Diluted Shares Outstanding		71.81M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$58.68M	$67.30M	$29.00M
YoY Change	125.3%	132.08%	63.84%
Cash & Equivalents	$48.68M	$56.60M	$14.42M
Short-Term Investments	$9.997M	$10.70M	$14.58M
Other Short-Term Assets	$2.710M	$2.620M	$2.860M
YoY Change	-9.06%	-8.39%	72.29%
Inventory	$3.913M	$3.877M	$3.580M
Prepaid Expenses
Receivables	$4.171M	$4.129M	$5.120M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$69.47M	$77.94M	$40.56M
YoY Change	88.4%	92.17%	26.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.642M	$2.785M	$5.520M
YoY Change	8.59%	-49.55%	106.74%
Goodwill	$900.0K	$921.0K
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$629.0K	$629.0K	$1.080M
YoY Change	44.6%	-41.76%	-55.0%
Total Long-Term Assets	$8.279M	$7.293M	$7.530M
YoY Change	11.23%	-3.15%	25.71%
TOTAL ASSETS
Total Short-Term Assets	$69.47M	$77.94M	$40.56M
Total Long-Term Assets	$8.279M	$7.293M	$7.530M
Total Assets	$77.75M	$85.24M	$48.09M
YoY Change	75.44%	77.24%	26.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.155M	$4.190M	$3.190M
YoY Change	37.67%	31.35%	-53.97%
Accrued Expenses	$5.013M	$4.968M	$5.400M
YoY Change	10.96%	-8.0%	98.53%
Deferred Revenue	$2.175M	$2.180M
YoY Change	-2.64%
Short-Term Debt	$0.00	$0.00	$1.150M
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$12.79M	$12.71M	$12.39M
YoY Change	3.39%	2.57%	-2.36%
LONG-TERM LIABILITIES
Long-Term Debt	$20.95M	$20.86M	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$9.600M	$11.99M
YoY Change	-100.0%	-19.93%	-5.81%
Total Long-Term Liabilities	$20.95M	$20.86M	$11.99M
YoY Change		73.94%	-5.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.79M	$12.71M	$12.39M
Total Long-Term Liabilities	$20.95M	$20.86M	$11.99M
Total Liabilities	$43.58M	$43.16M	$24.38M
YoY Change	81.6%	77.03%	-4.05%
SHAREHOLDERS EQUITY
Retained Earnings	-$337.4M	-$328.7M
YoY Change	10.08%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$34.17M	$42.08M	$23.70M
YoY Change
Total Liabilities & Shareholders Equity	$77.75M	$85.24M	$48.09M
YoY Change	75.44%	77.24%	26.29%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$8.660M	-$7.350M	-$7.855M
YoY Change	18.63%	-6.43%	58.05%
Depreciation, Depletion And Amortization	$220.0K	$200.0K	$200.0K
YoY Change	4.76%	0.0%	5.26%
Cash From Operating Activities	-$8.570M	-$4.920M	-$6.170M
YoY Change	61.7%	-20.26%	29.08%
INVESTING ACTIVITIES
Capital Expenditures	-$80.00K	-$690.0K	-$140.0K
YoY Change	-42.86%	392.86%	-44.0%
Acquisitions
YoY Change
Other Investing Activities	$710.0K	$2.570M	-$990.0K
YoY Change	129.03%	-359.6%	-113.08%
Cash From Investing Activities	$630.0K	$1.880M	-$1.140M
YoY Change	270.59%	-264.91%	-115.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	32.96M	320.0K
YoY Change	-100.0%	10200.0%
NET CHANGE
Cash From Operating Activities	-8.570M	-4.920M	-6.170M
Cash From Investing Activities	630.0K	1.880M	-1.140M
Cash From Financing Activities	0.000	32.96M	320.0K
Net Change In Cash	-7.940M	29.92M	-6.990M
YoY Change	201.9%	-528.04%	-375.2%
FREE CASH FLOW
Cash From Operating Activities	-$8.570M	-$4.920M	-$6.170M
Capital Expenditures	-$80.00K	-$690.0K	-$140.0K
Free Cash Flow	-$8.490M	-$4.230M	-$6.030M
YoY Change	64.53%	-29.85%	33.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity Registrant Name EntityRegistrantName	ROCKWELL MEDICAL, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Central Index Key EntityCentralIndexKey	0001041024
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-23661
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3317208
	dei	Entity Address Address Line1 EntityAddressAddressLine1	30142 S. Wixom Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	Wixom
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MI
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	48393
	dei	City Area Code CityAreaCode	248
	dei	Local Phone Number LocalPhoneNumber	960-9009
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001
	dei	Trading Symbol TradingSymbol	RMTI
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	93573165	shares
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56614000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11794000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	10702000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	14250000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4129000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4203000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	3877000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	3647000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2621000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2980000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	77943000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	36874000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2785000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2433000	USD
CY2020Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	859000	USD
CY2019Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	441000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2099000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3213000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	921000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	921000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	629000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	435000	USD
CY2020Q3	us-gaap	Assets Assets	85236000	USD
CY2019Q4	us-gaap	Assets Assets	44317000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4190000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3018000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4968000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4518000	USD
CY2020Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	USD
CY2019Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	104000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1155000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1493000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2180000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2234000	USD
CY2020Q3	us-gaap	Notes Payable NotesPayable	0	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	763000	USD
CY2020Q3	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	73000	USD
CY2019Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	55000	USD
CY2020Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	142000	USD
CY2019Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	188000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12708000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12373000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1039000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1781000	USD
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20856000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	8558000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9843000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	43161000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	23997000	USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2019Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93573165	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93573165	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65378890	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65378890	shares
CY2020Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	9000	USD
CY2019Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	7000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	370760000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	326777000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-328743000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-306516000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	49000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	52000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	42075000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	20320000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	85236000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44317000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15280000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15407000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47033000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	45812000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14934000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15424000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44693000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	44085000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	346000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	-17000	USD
	us-gaap	Gross Profit GrossProfit	2340000	USD
	us-gaap	Gross Profit GrossProfit	1727000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1669000	USD
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1827000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5738000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7149000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3622000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4623000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11767000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16341000	USD
CY2020Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2019Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	430000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1745000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1475000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5183000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4930000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6690000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-7942000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20348000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-27123000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	4000	USD
CY2019Q3	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	6000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	8000	USD
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	24000	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2019Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	837000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	666000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	16000	USD
	us-gaap	Interest Expense InterestExpense	1289000	USD
	us-gaap	Interest Expense InterestExpense	16000	USD
CY2020Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000	USD
CY2019Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	97000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	239000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	289000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-660000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	87000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1879000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	297000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-7350000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-7855000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-22227000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26826000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-100
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-120
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-320
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-450
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	71811322000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	63796723000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	69594167000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	59728446000	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-7350000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-7855000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-22227000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26826000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	2000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	6000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-11000	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	10000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7347000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7850000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22230000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26817000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	20320000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-7984000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	501000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	935000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	21774000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-6893000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-6000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-19000	USD
CY2020Q2	rmti	Adjustmentsto Additional Paidin Capital Warrant Modification Expense AdjustmentstoAdditionalPaidinCapitalWarrantModificationExpense	837000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-1461000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	16211000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-7350000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	2000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	250000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	42075000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	27277000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-8679000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-7000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	20161000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-10292000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	148000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-95000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1517000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	12000	USD
CY2019Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1502000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	29592000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-7855000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	6000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-85000	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	876000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	23702000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-22227000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-26826000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	614000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	582000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	-276000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3895000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	837000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	USD
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	305000	USD
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	1271000	USD
	rmti	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	1090000	USD
	rmti	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	1430000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	200000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-7000	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	8000	USD
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	24000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	953000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-293000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-7000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-74000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1857000	USD
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	0	USD
	us-gaap	Increase Decrease In Insurance Settlements Receivable IncreaseDecreaseInInsuranceSettlementsReceivable	-371000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-161000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-931000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1172000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1298000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-104000	USD
	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	-147000	USD
	rmti	Increase Decrease In Operating Lease Liabilites IncreaseDecreaseInOperatingLeaseLiabilites	-1056000	USD
	rmti	Increase Decrease In Operating Lease Liabilites IncreaseDecreaseInOperatingLeaseLiabilites	-1369000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	423000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1229000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1338000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1690000	USD
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	1621000	USD
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2281000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21072000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21954000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	23531000	USD
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	34202000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	27076000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	30479000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	970000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	449000	USD
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	0	USD
	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	750000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2575000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4922000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	22500000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1343000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	763000	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	763000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	148000	USD
	rmti	Repurchase Of Common Shares To Pay Employee Withholding Taxes RepurchaseOfCommonSharesToPayEmployeeWithholdingTaxes	18000	USD
	rmti	Repurchase Of Common Shares To Pay Employee Withholding Taxes RepurchaseOfCommonSharesToPayEmployeeWithholdingTaxes	180000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	63317000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18583000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	44820000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8293000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11794000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22714000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56614000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14421000	USD
	us-gaap	Stock Issued1 StockIssued1	501000	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-11000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
	us-gaap	Notes Assumed1 NotesAssumed1	0	USD
	us-gaap	Notes Assumed1 NotesAssumed1	1145000	USD
	us-gaap	Interest Paid Net InterestPaidNet	906000	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56600000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	10700000	USD
CY2020Q3	rmti	Working Capital Net WorkingCapitalNet	65200000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-328700000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21100000	USD
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3670212	shares
CY2020Q1	rmti	Proceeds From Issuance Of Common Stock Net Of Stock Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfStockIssuanceCosts	8000000.0	USD
CY2020Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	21200000	USD
CY2020Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	23178809	shares
CY2020Q3	rmti	Proceeds From Issuance Of Common Stock Net Of Stock Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfStockIssuanceCosts	32700000	USD
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1128608	shares
	rmti	Proceeds From Issuance Of Common Stock Net Of Stock Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfStockIssuanceCosts	2300000	USD
	rmti	Saleof Stock Remaining Sales Amount SaleofStockRemainingSalesAmount	32300000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</span></div>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33501260	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12412135	shares
	rmti	Number Of Distribution And License Agreements NumberOfDistributionAndLicenseAgreements	4	agreement
	rmti	Average Payment Term Of Customers AveragePaymentTermOfCustomers	P30D
	rmti	Average Payment Term Of Distributors AveragePaymentTermOfDistributors	P45D
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15280000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47033000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15407000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	45812000	USD
CY2020Q3	us-gaap	Other Receivables OtherReceivables	4129000	USD
CY2019Q4	us-gaap	Other Receivables OtherReceivables	4203000	USD
CY2020Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10738000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	12076000	USD
CY2019Q3	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
CY2020Q3	us-gaap	Contract With Customer Asset Credit Loss Expense ContractWithCustomerAssetCreditLossExpense	0	USD
CY2020Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2019Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10700000	USD
CY2020Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	10679000	USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000	USD
CY2020Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000	USD
CY2020Q3	rmti	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	21000	USD
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	10702000	USD
CY2019Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	14238000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000	USD
CY2019Q4	rmti	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossCurrent	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	14250000	USD
CY2020Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2794000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2471000	USD
CY2020Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	329000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	185000	USD
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1613000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1432000	USD
CY2020Q3	rmti	Current And Non Current Inventory CurrentAndNonCurrentInventory	4736000	USD
CY2019Q4	rmti	Current And Non Current Inventory CurrentAndNonCurrentInventory	4088000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9105000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8298000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6320000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5865000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2785000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2433000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	200000	USD
CY2019Q3	us-gaap	Depreciation Depreciation	200000	USD
	us-gaap	Depreciation Depreciation	600000	USD
	us-gaap	Depreciation Depreciation	600000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2584000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1018000	USD
CY2020Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	172000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	182000	USD
CY2020Q3	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	258000	USD
CY2019Q4	rmti	Research And Development Related Liabilities Current ResearchAndDevelopmentRelatedLiabilitiesCurrent	283000	USD
CY2020Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	100000	USD
CY2019Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	61000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1854000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2974000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4968000	USD
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	170000000	shares
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4518000	USD
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	93573165	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	93573165	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	65378890	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	65378890	shares
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.068
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.068
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.068
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.068
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2100000	USD
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	382000	USD
CY2019Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	532000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	1228000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	1592000	USD
CY2020Q3	us-gaap	Variable Lease Cost VariableLeaseCost	90000	USD
CY2019Q3	us-gaap	Variable Lease Cost VariableLeaseCost	90000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	403000	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	258000	USD
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	472000	USD
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	622000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1631000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	1850000	USD
CY2020Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	USD
CY2019Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	4000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	12000	USD
CY2020Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	98000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2366000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1532000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	172000	USD
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	12000	USD
CY2020Q3	us-gaap	Lease Cost LeaseCost	476000	USD
CY2019Q3	us-gaap	Lease Cost LeaseCost	626000	USD
	us-gaap	Lease Cost LeaseCost	1643000	USD
	us-gaap	Lease Cost LeaseCost	1862000	USD
CY2020Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	393000	USD
CY2019Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	494000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	1248000	USD
CY2019Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	136000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4442000	USD
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2194000	USD
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	3000000.0	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	387000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1055000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	592000	USD
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	234000	USD
CY2020Q3	rmti	Supply Agreement Percentage Of Raw Materials To Be Paid SupplyAgreementPercentageOfRawMaterialsToBePaid	0.50
CY2020Q3	rmti	Supply Agreement Percentage Of Raw Materials Paid SupplyAgreementPercentageOfRawMaterialsPaid	0.50
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	250000	USD
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	877000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-276000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3895000	USD
	rmti	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue	12074	USD
CY2018Q4	rmti	Number Of Additional Agreements NumberOfAdditionalAgreements	3	agreement
CY2020Q3	rmti	Related Party Transactions Accrued Reimbursement Of Ip Expenses And Sublicense Royalty Fees RelatedPartyTransactionsAccruedReimbursementOfIPExpensesAndSublicenseRoyaltyFees	100000	USD
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2200000	USD
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	400000	USD

Files In Submission

Name	View Source	Status
0001628280-20-016121-index-headers.html	Edgar Link	pending
0001628280-20-016121-index.html	Edgar Link	pending
0001628280-20-016121.txt	Edgar Link	pending
0001628280-20-016121-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rmti-20200930.htm	Edgar Link	pending
rmti-20200930.xsd	Edgar Link	pending
rmti-20200930x10qex311.htm	Edgar Link	pending
rmti-20200930x10qex312.htm	Edgar Link	pending
rmti-20200930x10qex321.htm	Edgar Link	pending
rmti-20200930_cal.xml	Edgar Link	unprocessable
rmti-20200930_def.xml	Edgar Link	unprocessable
rmti-20200930_htm.xml	Edgar Link	completed
rmti-20200930_lab.xml	Edgar Link	unprocessable
rmti-20200930_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti

2020 Q4 Form 10-Q Financial Statement

#000162828020016121 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI ROCKWELL MEDICAL, INC. Stock $rmti

2020 Q4 Form 10-Q Financial Statement

#000162828020016121 Filed on November 09, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RMTI
ROCKWELL MEDICAL, INC. Stock $rmti